_version_ 1783711589166219264
author Miele, Monica
Busà, Rosalia
Russelli, Giovanna
Sorrentino, Maria Concetta
Di Bella, Mariangela
Timoneri, Francesca
Mularoni, Alessandra
Panarello, Giovanna
Vitulo, Patrizio
Conaldi, Pier Giulio
Bulati, Matteo
author_facet Miele, Monica
Busà, Rosalia
Russelli, Giovanna
Sorrentino, Maria Concetta
Di Bella, Mariangela
Timoneri, Francesca
Mularoni, Alessandra
Panarello, Giovanna
Vitulo, Patrizio
Conaldi, Pier Giulio
Bulati, Matteo
author_sort Miele, Monica
collection PubMed
description
format Online
Article
Text
id pubmed-8222937
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82229372021-06-25 Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients Miele, Monica Busà, Rosalia Russelli, Giovanna Sorrentino, Maria Concetta Di Bella, Mariangela Timoneri, Francesca Mularoni, Alessandra Panarello, Giovanna Vitulo, Patrizio Conaldi, Pier Giulio Bulati, Matteo Am J Transplant Letter to the Editor American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2021-08 2022-12-30 /pmc/articles/PMC8222937/ /pubmed/34058052 http://dx.doi.org/10.1111/ajt.16702 Text en Copyright © 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Miele, Monica
Busà, Rosalia
Russelli, Giovanna
Sorrentino, Maria Concetta
Di Bella, Mariangela
Timoneri, Francesca
Mularoni, Alessandra
Panarello, Giovanna
Vitulo, Patrizio
Conaldi, Pier Giulio
Bulati, Matteo
Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
title Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
title_full Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
title_fullStr Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
title_full_unstemmed Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
title_short Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
title_sort impaired anti-sars-cov-2 humoral and cellular immune response induced by pfizer-biontech bnt162b2 mrna vaccine in solid organ transplanted patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222937/
https://www.ncbi.nlm.nih.gov/pubmed/34058052
http://dx.doi.org/10.1111/ajt.16702
work_keys_str_mv AT mielemonica impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT busarosalia impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT russelligiovanna impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT sorrentinomariaconcetta impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT dibellamariangela impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT timonerifrancesca impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT mularonialessandra impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT panarellogiovanna impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT vitulopatrizio impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT conaldipiergiulio impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients
AT bulatimatteo impairedantisarscov2humoralandcellularimmuneresponseinducedbypfizerbiontechbnt162b2mrnavaccineinsolidorgantransplantedpatients